Brefonalol

From WikiMD's WELLNESSPEDIA

Brefonalol

Brefonalol is a pharmacological agent that acts as a beta-adrenergic antagonist, also commonly referred to as a beta-blocker. Beta-adrenergic antagonists are a class of drugs that impede the activation of beta-adrenoceptors by endogenous catecholamines, thus affecting the heart, blood vessels, and various other tissues.

Pharmacology[edit]

Mechanism of Action[edit]

Brefonalol, like other beta-blockers, exerts its therapeutic effects by blocking the activation of beta-adrenoceptors. By doing so, it counteracts the stimulatory effects of neurotransmitters like adrenaline and noradrenaline, leading to decreased heart rate, blood pressure, and workload on the heart.

Therapeutic Uses[edit]

While Brefonalol has potential therapeutic properties similar to other beta-blockers, the specific indications for its use would depend on clinical trials and regulatory approvals.

Typically, beta-blockers are prescribed for:

  • Hypertension (high blood pressure)
  • Angina pectoris (chest pain)
  • Arrhythmia (irregular heartbeats)
  • Heart failure management
  • Protection after a heart attack
  • Migraine prophylaxis

Side Effects[edit]

Beta-adrenergic antagonists, including Brefonalol, can have various side effects due to their action on the cardiovascular system and other organs. Commonly reported side effects may include:

  • Fatigue
  • Cold extremities
  • Slow heart rate (bradycardia)
  • Depression
  • Sleep disturbances
  • Nausea

Contraindications[edit]

Patients with certain medical conditions should exercise caution or avoid the use of Brefonalol:

  • Severe asthma or chronic obstructive pulmonary disease (COPD)
  • Certain heart conditions like severe bradycardia or heart block
  • Severe heart failure

Pharmacokinetics[edit]

The absorption, distribution, metabolism, and excretion of Brefonalol would be key considerations for determining its dosing regimen, drug interactions, and potential toxicities.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Brefonalol&oldid=4968849"